Detection of genes for superantigen toxins in methicillin-resistant Staphylococcus aureus clinical isolates in

Yasmeen Taj1, Izhar Fatima1, Syed Wajid Ali1

  • 1Department of Pathology, Dow Medical College, Dow University of Health Sciences, Karachi.

Abstract

Insights

Staphylococcus aureus (S. aureus) clinical isolates frequently carry toxin genes, especially in methicillin-resistant strains (MRSA). Polymerase Chain Reaction (PCR) effectively detects these toxin genes, indicating a common trait in MRSA.

Area of Science:

  • Molecular Biology
  • Clinical Microbiology
  • Bacterial Genetics

Background:

  • Staphylococcus aureus (S. aureus) is a significant human pathogen.
  • Toxin production by S. aureus contributes to its virulence.
  • Methicillin-resistant S. aureus (MRSA) poses a growing public health threat.

Purpose of the Study:

  • To detect genes encoding enterotoxins, exfoliative toxins, and toxic shock syndrome toxins in S. aureus clinical isolates.
  • To compare the prevalence of these toxin genes in methicillin-resistant S. aureus (MRSA) versus methicillin-sensitive S. aureus (MSSA).

Main Methods:

  • A cross-sectional observational study was conducted.
  • 298 S. aureus clinical isolates were analyzed from samples at Dr. Ziauddin Hospital, Karachi.
  • Polymerase Chain Reaction (PCR) with uniplex primers was used to detect specific toxin genes.

Main Results:

  • 115 isolates (38.6%) were identified as MRSA.
  • Toxin genes were present in 61.73% of MRSA isolates across various sample types (pus, sputum, blood, urine).
  • The prevalence of toxin genes was significantly higher in MRSA (61.73%) compared to MSSA (19.12%).

Conclusions:

  • Polymerase Chain Reaction (PCR) is a reliable method for detecting toxin genes in S. aureus, irrespective of their expression.
  • The presence of super-antigen genes is a common characteristic of S. aureus, particularly prevalent in MRSA strains.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143